Literature DB >> 16503799

Rapid elimination of protein S-100B from serum after minor head trauma.

Will Townend1, Colin Dibble, Kamran Abid, Andy Vail, Roy Sherwood, Fiona Lecky.   

Abstract

Protein S-100B is released into the circulation after traumatic brain injury, and its serum concentration relates to measures of injury severity and outcome. These properties have led to interest in its development as a marker for clinical use, particularly in the prediction of adverse outcome for those with apparently trivial injuries. Before it can be used in populations of patients with head injuries, however, more needs to be understood about its release and elimination. This study was designed to estimate the elimination half-life of S-100B from the circulation after minor head trauma. We studied 14 patients with minor head injuries and measured serum S-100B serially after initial assessment in the Emergency Department of an inner city teaching hospital. We used curve-fit analysis to estimate the elimination constant that best fitted our data, and from this estimated the elimination half-life of protein S-100B. We estimated the mean half-life in this setting to be 97 min (95% confidence interval [CI] of 75-136 min). S-100B is cleared rapidly, relative to the time elapsed between injury and initial assessment in the Emergency Department. Variation in the time elapsed between injury and sampling is likely to influence the accuracy of head injury outcome prediction based on S-100B concentrations in serum, and should be considered when designing future studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503799     DOI: 10.1089/neu.2006.23.149

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  29 in total

1.  [Serological determination of protein S100B. Significance in emergency diagnosis of adults with mild craniocerebral trauma--meta-analysis].

Authors:  B A Leidel; V Bogner; M Zock; K-G Kanz
Journal:  Unfallchirurg       Date:  2012-10       Impact factor: 1.000

Review 2.  A systematic review of the biomarker S100B: implications for sport-related concussion management.

Authors:  Stefanie Schulte; Leslie W Podlog; J Jordan Hamson-Utley; Frederick G Strathmann; Heiko K Strüder
Journal:  J Athl Train       Date:  2014 Nov-Dec       Impact factor: 2.860

3.  Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression.

Authors:  Laura Kranaster; Christoph Janke; Sonani Mindt; Michael Neumaier; Alexander Sartorius
Journal:  J Neural Transm (Vienna)       Date:  2014-05-07       Impact factor: 3.575

4.  The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.

Authors:  Michael V DeFazio; Richard A Rammo; Jaime R Robles; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  World Neurosurg       Date:  2013-01-08       Impact factor: 2.104

Review 5.  Blood biomarkers for brain injury: What are we measuring?

Authors:  Keisuke Kawata; Charles Y Liu; Steven F Merkel; Servio H Ramirez; Ryan T Tierney; Dianne Langford
Journal:  Neurosci Biobehav Rev       Date:  2016-05-12       Impact factor: 8.989

6.  Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.

Authors:  Jeffrey J Bazarian; Brian J Blyth; Hua He; Sohug Mookerjee; Courtney Jones; Karin Kiechle; Ryan Moynihan; Susan M Wojcik; William D Grant; LaLainia M Secreti; Wayne Triner; Ronald Moscati; August Leinhart; George L Ellis; Jawwad Khan
Journal:  J Neurotrauma       Date:  2013-08-24       Impact factor: 5.269

7.  Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.

Authors:  Denes V Agoston; Mohammad Elsayed
Journal:  Front Neurol       Date:  2012-07-06       Impact factor: 4.003

8.  A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury.

Authors:  Sima Azizi; Daniel B Hier; Blaine Allen; Tayo Obafemi-Ajayi; Gayla R Olbricht; Matthew S Thimgan; Donald C Wunsch
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

9.  Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery.

Authors:  J D Guingab-Cagmat; E B Cagmat; R L Hayes; J Anagli
Journal:  Front Neurol       Date:  2013-05-31       Impact factor: 4.003

10.  Clinical significance of serum S100B levels in neurointensive care.

Authors:  Johan Undén; Ramona Astrand; Knut Waterloo; Tor Ingebrigtsen; Johan Bellner; Peter Reinstrup; Gunnar Andsberg; Bertil Romner
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.